These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 19194108

  • 1. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 3. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG.
    Nephron Clin Pract; 2008 Apr; 110(2):c93-100. PubMed ID: 18815449
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C.
    Int J Cardiol; 2008 Jul 21; 127(3):321-7. PubMed ID: 18055041
    [Abstract] [Full Text] [Related]

  • 5. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP.
    Arch Mal Coeur Vaiss; 2004 Sep 21; 97(9):881-8. PubMed ID: 15521481
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.
    Am J Nephrol; 2009 Sep 21; 29(6):516-23. PubMed ID: 19077418
    [Abstract] [Full Text] [Related]

  • 7. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 8. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM, Almeida R, Araújo JP, Azevedo A, Friões F, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    J Card Fail; 2007 May 03; 13(4):275-80. PubMed ID: 17517347
    [Abstract] [Full Text] [Related]

  • 9. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O, Paz H, Ammar R, Yaniv N, Schliamser JE, Lewis BS.
    Isr Med Assoc J; 2008 Feb 03; 10(2):109-12. PubMed ID: 18432021
    [Abstract] [Full Text] [Related]

  • 10. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P.
    Int J Cardiol; 2008 Oct 13; 129(3):373-8. PubMed ID: 18054808
    [Abstract] [Full Text] [Related]

  • 11. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul 13; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 12. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D.
    Nephrol Dial Transplant; 2010 Feb 13; 25(2):551-7. PubMed ID: 19679559
    [Abstract] [Full Text] [Related]

  • 13. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.
    Kidney Blood Press Res; 2009 Feb 13; 32(5):373-9. PubMed ID: 19887825
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C, Reinecke H, Stypmann J, Rothenburger M, Schmid C, Breithardt G, Wichter T, Gradaus R.
    J Heart Lung Transplant; 2006 Sep 13; 25(9):1135-41. PubMed ID: 16962477
    [Abstract] [Full Text] [Related]

  • 15. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M.
    Eur J Clin Invest; 2007 May 13; 37(5):350-6. PubMed ID: 17461980
    [Abstract] [Full Text] [Related]

  • 16. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ.
    Am Heart J; 2007 Jan 13; 153(1):36-41. PubMed ID: 17174634
    [Abstract] [Full Text] [Related]

  • 17. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J, Králová H, Trefil L, Rajdl D, Eiselt J.
    Nephron Clin Pract; 2006 Jan 13; 103(4):c162-72. PubMed ID: 16645318
    [Abstract] [Full Text] [Related]

  • 18. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S, Webb MC, Price CP, John RI, Abbas NA, Lamb EJ.
    Nephrol Dial Transplant; 2008 Nov 13; 23(11):3546-53. PubMed ID: 18562472
    [Abstract] [Full Text] [Related]

  • 20. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL.
    Arch Intern Med; 2007 Feb 26; 167(4):400-7. PubMed ID: 17325303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.